Ezetimibe + Bempedoic acid combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ezetimibe + Bempedoic acid combination, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn) [Phase 3]